Obesity and Obesity-Related Hypertension in Northern Cyprus: Findings from a Population-Based Cross-Sectional Study
Abstract
BACKGROUND/AIMS:Obesity constitutes a chronic and multifactorial condition characterized by an excessive accumulation of adipose tissue and is linked to a wide range of comorbidities, including hypertension (HT).Its predominant cause is the disparity between caloric intake and the body's energy utilization.As obesity rates persistently rise, the incidence of obesity-related conditions, particularly HT, is expected to increase.This study estimated the prevalence of general and abdominal obesity (AO) and obesity-related HT among adults in Northern Cyprus. MATERIALS AND METHODS:In this cross-sectional observational study, data were collected between October 2023 and June 2024 from Turkish Cypriot adults aged 18-79 years residing in Northern Cyprus. RESULTS:The population-level prevalences of general obesity, AO, and excess weight were 26.2%, 46.9%, and 63.2%, respectively.Obesity prevalence was higher in males (29.7%) than in females (23.1%), and excess weight affected 74.3% of males and 53.2% of females.AO was also more prevalent among males (49.6%) than among females (44.4%).The population-level prevalence of HT was 34.6% (36.1% in males, 33.1% in females).Among individuals with HT, 76.9% had obesity-related HT (77.6% among males and 76.1% among females).CONCLUSION: Obesity and its associated HT are highly prevalent among adults in Northern Cyprus.With rising obesity rates, the burden of obesity-related conditions is likely to increase.Prevention strategies, alongside lifestyle interventions, anti-obesity pharmacotherapy, and metabolic surgery when appropriate, are essential for long-term control of weight and blood pressure.
Fields of Study & Subjects
Blood Pressure and Hypertension Studies
Obesity
Physical Activity
Diet
Diabetes
Cardiovascular Risks
and Lipoproteins
Publication details
- Journal / source
- Cyprus Journal of Medical Sciences
- Volume
- 11
- Issue
- 1
- Publication date
- 17 February 2026
- Language
- EN